COVID-19 and biomarkers of thrombosis: focus on von Willebrand factor and extracellular vesicles
Journal of Thrombosis and Thrombolysis · 2021-11 · 52 (4) · 1010-1019
DOI: 10.1007/s11239-021-02544-x ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Thrombosis and Thrombolysis, online erschienen am 04.08.2021. Verfasst von Richard C Becker und 3 weiteren Autor:innen. Beteiligte Einrichtung: Heart, Lung and Vascular Institute, University of Cincinnati College of Medicine, 231 Albert Sabin Way, Cincinnati, OH, 45267, USA. richard.becker@uc…. Hauptthemen laut MEDLINE: COVID-19, Extracellular Vesicles, Thrombosis, von Willebrand Factor. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
COVID-19, caused by the SARS-CoV-2 virus, is responsible for a pandemic of unparalleled portion over the past century. While the acute phase of infection causes significant morbidity and mortality, post-acute sequelae that can affect essentially any organ system is rapidly taking on an equally large part of the overall impact on human health, quality of life, attempts to return to normalcy and the global economy. Herein, we summarize the potential role of von Willebrand Factor and extracellular vesicles toward understanding the pathophysiology, clinical presentation, duration of illness, diagnostic approach and management of COVID-19 and its sequelae.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Heart, Lung and Vascular Institute, University of Cincinnati College of Medicine, 231 Albert Sabin Way, Cincinnati, OH, 45267, USA. richard.becker@uc.edu.
- The Gill Heart and Vascular Institute, University of Kentucky, Lexington, KY, USA.
- University of Arkansas for Medical Sciences, Little Rock, AK, USA.
Zitieren
APA
Becker, R. C., Sexton, T., Smyth, S., & International COVID-19 Thrombosis Biomarkers Colloquium (ICODE) Investigators (2021). COVID-19 and biomarkers of thrombosis: focus on von Willebrand factor and extracellular vesicles. Journal of Thrombosis and Thrombolysis, 52(4), 1010-1019. https://doi.org/10.1007/s11239-021-02544-x
Vancouver
Becker RC, Sexton T, Smyth S, International COVID-19 Thrombosis Biomarkers Colloquium (ICODE) Investigators. COVID-19 and biomarkers of thrombosis: focus on von Willebrand factor and extracellular vesicles. Journal of Thrombosis and Thrombolysis. 2021;52(4):1010-1019. doi:10.1007/s11239-021-02544-x
BibTeX
@article{Becker2021,
author = {Becker, Richard C and Sexton, Travis and Smyth, Susan and International COVID-19 Thrombosis Biomarkers Colloquium (ICODE) Investigators, International COVID-19 Thrombosis Biomarkers Colloquium (ICODE) Investigators},
title = {COVID-19 and biomarkers of thrombosis: focus on von Willebrand factor and extracellular vesicles},
journal = {Journal of Thrombosis and Thrombolysis},
year = {2021},
volume = {52},
number = {4},
pages = {1010--1019},
doi = {10.1007/s11239-021-02544-x}
}
EUVIMED